Factors Associated With Chronic Intestinal Inflammation Resembling Inflammatory Bowel Disease in Pediatric Intestinal Failure: A Matched Case-Control Study

被引:7
作者
Culbreath, Katherine [1 ,2 ,3 ]
Keefe, Gregory [1 ,2 ,3 ]
Nes, Emily [1 ,2 ,3 ]
Staffa, Steven J. [1 ,2 ]
Carey, Alexandra N. [2 ,3 ,4 ]
Jaksic, Tom [1 ,2 ,3 ]
Goldsmith, Jeffrey D. [2 ,5 ]
Modi, Biren P. [1 ,2 ,3 ]
Ouahed, Jodie D. [2 ,3 ,4 ,6 ]
Jimenez, Lissette [2 ,3 ,4 ,7 ]
机构
[1] Boston Childrens Hosp, Dept Surg, Boston, MA 02115 USA
[2] Harvard Med Sch, Boston, MA USA
[3] Boston Childrens Hosp, Ctr Adv Intestinal Rehabil, Boston, MA 02115 USA
[4] Boston Childrens Hosp, Div Gastroenterol Hepatol & Nutr, Boston, MA 02115 USA
[5] Boston Childrens Hosp, Dept Pathol, Boston, MA 02115 USA
[6] Boston Childrens Hosp, Inflammatory Bowel Dis Ctr, Boston, MA 02115 USA
[7] Boston Childrens Hosp, 33 3Longwood Ave,4th Floor,LO410, Boston, MA 02115 USA
关键词
bacterial overgrowth; intestinal failure; parenteral nutrition; CROHNS-DISEASE; GUT MICROBIOTA; MAINTENANCE; CHILDREN;
D O I
10.1097/MPG.0000000000003718
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aims:There is a subset of intestinal failure patients with associated chronic intestinal inflammation resembling inflammatory bowel disease. This study aimed to evaluate factors associated with chronic intestinal inflammation in pediatric intestinal failure. Methods:This was a single-center retrospective case-control study of children <18 years old with intestinal failure. Cases were defined by abnormal amounts of chronic intestinal inflammation on biopsies. Children with diversion colitis, eosinophilic colitis, or isolated anastomotic ulceration were excluded. Cases were matched 1:2 to intestinal failure controls based on sex, etiology of intestinal failure, and duration of intestinal failure. Multivariable conditional logistic regression was used to compare clinical factors between cases and controls, accounting for clustering within matched sets. A subgroup analysis was performed assessing factors associated with escalation of anti-inflammatory therapy. Results:Thirty cases were identified and matched to 60 controls. On univariate analysis, longer parenteral nutrition (PN) duration (1677 vs 834 days, P = 0.03), current PN use (33.3% vs 20.0%, P = 0.037), and culture-proven bacterial overgrowth (53.3% vs 31.7%, P = 0.05) were associated with chronic intestinal inflammation. On multivariable analysis, no variable reached statistical significance. On subgroup analysis, duration of intestinal failure, location of inflammation, and worst degree of inflammation on histology were associated with escalation of therapy. Conclusions:PN dependence and intestinal dysbiosis are associated with chronic intestinal inflammation in children with intestinal failure. Severity of inflammation is associated with escalation of therapy. Further analysis is needed to assess these associations and the efficacy of treatments in this population.
引用
收藏
页码:468 / 474
页数:7
相关论文
共 50 条
[21]   Management of intestinal failure in inflammatory bowel disease: Small intestinal transplantation or home parenteral nutrition? [J].
Harrison, Elizabeth ;
Allan, Philip ;
Ramu, Amrutha ;
Vaidya, Anil ;
Travis, Simon ;
Lal, Simon .
WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (12) :3153-3163
[22]   Risk Factors for Lymphoma in Patients with Inflammatory Bowel Disease: A Case-control Study [J].
Afif, Waqqas ;
Sandborn, William J. ;
Faubion, William A. ;
Rahman, Meher ;
Harmsen, Scott W. ;
Zinsmeister, Alan R. ;
Loftus, Edward V., Jr. .
INFLAMMATORY BOWEL DISEASES, 2013, 19 (07) :1384-1389
[23]   Dietary risk factors for inflammatory bowel disease in Shanghai: A case-control study [J].
Mi, Lin ;
Zhang, Chen ;
Yu, Xiao-feng ;
Zou, Jian ;
Yu, Yang ;
Bao, Zhi-Jun .
ASIA PACIFIC JOURNAL OF CLINICAL NUTRITION, 2022, 31 (03) :405-414
[24]   Disruption of the Hedgehog signaling pathway in inflammatory bowel disease fosters chronic intestinal inflammation [J].
Fernanda Buongusto ;
Claudio Bernardazzi ;
Agnes N. Yoshimoto ;
Hayandra F. Nanini ;
Raquel L. Coutinho ;
Antonio Jose V. Carneiro ;
Morgana T. Castelo-Branco ;
Heitor S. de Souza .
Clinical and Experimental Medicine, 2017, 17 :351-369
[25]   Disruption of the Hedgehog signaling pathway in inflammatory bowel disease fosters chronic intestinal inflammation [J].
Buongusto, Fernanda ;
Bernardazzi, Claudio ;
Yoshimoto, Agnes N. ;
Nanini, Hayandra F. ;
Coutinho, Raquel L. ;
Carneiro, Antonio Jose V. ;
Castelo-Branco, Morgana T. ;
de Souza, Heitor S. .
CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 17 (03) :351-369
[26]   Hemorheology in Inflammatory Bowel Disease: A Case-Control Study [J].
Szakacs, Zsolt ;
Csiszar, Beata ;
Nagy, Matyas ;
Tokes-Fuzesi, Margit ;
Sarlos, Patricia ;
Toth, Kalman ;
Hegyi, Peter ;
Alizadeh, Hussain ;
Bajor, Judit .
JOURNAL OF CLINICAL MEDICINE, 2025, 14 (13)
[27]   Efficacy and safety of vedolizumab in elderly patients with inflammatory bowel disease: a matched case-control study [J].
Shashi, Preeti ;
Gopalakrishnan, Dharmesh ;
Parikh, Malay P. ;
Shen, Bo ;
Kochhar, Gursimran .
GASTROENTEROLOGY REPORT, 2020, 8 (04) :306-311
[28]   Factors Related to the Development of Small-Bowel Bacterial Overgrowth in Pediatric Intestinal Failure: A Retrospective Cohort Study [J].
Belza, Christina ;
Betts, Zachary ;
de Silva, Nicole ;
Avitzur, Yaron ;
Wales, Paul W. .
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 2020, 44 (07) :1280-1284
[29]   Managing intestinal failure in inflammatory bowel disease - 'when the drugs don't work' [J].
Morgan, James ;
Bond, Ashley ;
Kullu, Cecil ;
Subramanian, Sreedhar ;
Dibb, Martyn ;
Smith, Philip J. .
FRONTLINE GASTROENTEROLOGY, 2021, 12 (05) :414-422
[30]   Wip 1 inhibits intestinal inflammation in inflammatory bowel disease [J].
Zhang, Qi ;
Zhang, Cuiping ;
Chang, Fangzhi ;
Liang, Kun ;
Yin, Xiaoyan ;
Li, Xiaoyu ;
Zhao, Kun ;
Niu, Qinghui ;
Tian, Zibin .
CELLULAR IMMUNOLOGY, 2016, 310 :63-70